| Original data | Imputed data$ | |||
---|---|---|---|---|---|
 | 2017–2019 | 2020 | 2017–2019 | 2020 | Difference (%)** |
 | N (%)* | N (%) | N (%)* | N (%) | Δ [95% CI] |
Sex | Â | Â | Â | Â | Â |
 Male | 611 (67%) | 508 (70%) | 617 (68%) | 510 (70%) | − 17.3% [− 22.6%; − 11.9%] |
 Female | 286 (32%) | 213 (29%) | 289 (32%) | 215 (30%) | − 25.9% [− 36.8%; − 14.9%] |
Missing | 9 (1%) | 4 (1%) | Â | Â | Â |
Age group | Â | Â | Â | Â | Â |
  < 30 | 234 (26%) | 170 (23%) | 234 (26%) | 174 (24%) | − 25.6% [− 38.3%; − 13.0%] |
 30–49 | 489 (54%) | 409 (56%) | 489 (54%) | 409 (56%) | − 16.4% [− 23.8%; − 9.1%] |
  ≥ 50 | 183 (20%) | 142 (20%) | 183 (20%) | 142 (20%) | − 22.4% [− 37.6%; − 7.2%] |
Missing | 0 (0%) | 4 (1%) | Â | Â | Â |
Nationality | Â | Â | Â | Â | Â |
 Belgian | 302 (33%) | 182 (25%) | 355 (39%) | 232 (32%) | − 34.6% [− 43.8%; − 25.5%] |
 European | 126 (14%) | 142 (20%) | 144 (16%) | 159 (22%) |  + 10.8% [− 13.0%; + 34.5%] |
 Subs. African | 218 (24%) | 149 (21%) | 269 (30%) | 185 (26%) | − 31.3% [− 42.8%; − 19.7%] |
 Other | 123 (14%) | 131 (18%) | 138 (15%) | 149 (20%) |  + 7.7% [− 17.3%; + 32.8%] |
Missing | 137 (15%) | 121 (16%) | Â | Â | Â |
Mode of infection | Â | Â | Â | Â | Â |
 MSM | 344 (38%) | 248 (34%) | 413 (46%) | 336 (46%) | − 18.5% [− 27.9%; − 9.2%] |
 Heterosexual | 345 (38%) | 247 (34%) | 452 (50%) | 353 (49%) | − 21.9% [− 3.05%; − 13.3%] |
 PWID | 12 (1%) | 6 (1%) | 18 (2%) | 13 (2%) | − 26.4% [− 94.5%; + 41.8%] |
 Other | 14 (2%) | 15 (2%) | 23 (3%) | 23 (3%) | − 1.7% [− 65.4%; − 62.0%] |
Missing | 191 (21%) | 209 (29%) | Â | Â | Â |